VR Interventions to Reduce the Prevalence of Delirium in ICU Patients

Sponsor
Peking Union Medical College Hospital
Study ID
NCT05525702
Status
Recruiting
Apply to this trial

Conditions

  • Delirium

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • VRFS — DEVICE
    Participants wear VR headsets and experience immersive virtual environments, where their family members will be present and offer companionship and comfort.

Study Details

The goal of this clinical trial is to learn the effect of Virtual Reality Family Support System (VRFS) on reducing delirium in ICU mechanically ventilated patients. The main question it aims to answer is: ·Using VRFS for participant intervention, can it reduce the incidence of delirium and improve clinical outcomes? Researchers will investigate whether the implementation of VRFS can reduce the number of delirium days and improve clinical outcomes. Participants will: * Receive the VRFS intervention until the endotracheal tube (ETT) is removed. * Have physiological data collected, including EEG, oxygen saturation levels, ECG, and blood pressure. * Keep a diary of delirium, dosage of sedative and analgesic drugs, the duration of mechanical ventilation, and ICU stays.

Key Dates

First listed
Sep 1, 2022
Start date
Dec 18, 2023
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
102 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: VRFS Intervention
    Participants will receive standard ICU care and will also undergo VRFS intervention.
  • No Intervention: Standard ICU Care
    Patients will be treated with standard ICU care and not receive VR stimulation.

Primary Outcome Measure

Delirium Day [ Time Frame: Twice daily from Day 1 through ICU discharge, an average of 7 days. ]

Central Contacts

Related Studies